❓ Hon Sue Ellery requests information on payments made to pharmaceutical and medical supply companies by WA Health since April 2010. Hon Helen Morton acknowledges the request but states the current financial systems cannot provide the specific data without further refinement of the request.
AnsweredQoN 620Legislative Council
QuestionView source ↗
PHARMACEUTICAL COMPANIES — INDIVIDUAL PAYMENTS
(1) Which pharmaceutical companies have received individual payments for the provision of pharmaceuticals, medical devices or medical equipment since 1 April 2010? (2) How much was paid to each listed in (1)? Hon HELEN MORTON
(1) Which pharmaceutical companies have received individual payments for the provision of pharmaceuticals, medical devices or medical equipment since 1 April 2010? (2) How much was paid to each listed in (1)? Hon HELEN MORTON
AnswerView source ↗
I thank the honourable member for some notice of this question. (1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
(2) How much was paid to each listed in (1)? Hon HELEN MORTON replied: I thank the honourable member for some notice of this question. (1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
Hon HELEN MORTON replied: I thank the honourable member for some notice of this question. (1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
I thank the honourable member for some notice of this question. (1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
(1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
(2) How much was paid to each listed in (1)? Hon HELEN MORTON replied: I thank the honourable member for some notice of this question. (1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
Hon HELEN MORTON replied: I thank the honourable member for some notice of this question. (1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
I thank the honourable member for some notice of this question. (1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
(1)–(2) WA Health financial systems identify more than 120 companies from which a minimum of $100 000 was spent on these types of expenditures over this period. Companies do not necessarily identify themselves as pharmaceutical companies; therefore, this list contains non-pharmaceutical companies. WA Health requires further refinement of the request to be able to respond appropriately.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.